Has Raul Marquez, MD received payments from drug or device companies?

Yes. Drug and device makers reported $278,244 in general payments to Raul Marquez, MD across 143 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Raul Marquez, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Raul Marquez, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Raul Marquez, MD

Adult Reconstructive Orthopaedic Surgery · Edinburg, TXNPI 1164434320

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (50.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 16 manufacturers reported payments, led by Smith+Nephew at 55.7% of the total. Reporting peaked in 2019 at $145,280 and has fallen 99.9% since, to $94 in 2025. Among adult reconstructive orthopaedic surgery clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$278,244in general payments, 2019–2025

Across 143 payments — averaging $1945.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Smith+Nephew$155K
Exactech, Inc.$84K
Zimmer Biomet$12K
Aesculap Implant Systems, LLC$11K
Think Surgical, Inc.$10K
Medinc Of Texas$2K
plus $4K from 10 others

$61,911in research payments, 2019–2025

Across 3 payments — averaging $20,637 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Novartis$44K
GRT US Holding, Inc.$10K
Exactech, Inc.$8K

What the payments were for

Royalty or licence$139,21750%
Consulting fees$98,09735%
Travel & lodging$19,6797%
Food & beverage$4,5352%
Education$1,2000%
Entertainment$1410%
Other$15,3766%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Smith+Nephew	24	$154,944
Exactech, Inc.	43	$83,901
Zimmer Biomet	21	$12,097
Aesculap Implant Systems, LLC	8	$11,002
Think Surgical, Inc.	8	$9,861
Medinc Of Texas	4	$2,251
Omnilife Science, Inc	10	$1,639
Linvatec Corporation	6	$967
Ortho Development Corporation	6	$643
Arthrex	2	$448
Orthalign Inc	3	$372
Ferring Pharmaceuticals Inc.	3	$38
Surgical Specialties Corporation (US), Inc. (dba Corza Medical)	1	$25
Amgen	2	$22
Pfizer	1	$18
Bioventus LLC	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$278,244 in reported general payments places this provider in the 90th percentile of 86 adult reconstructive orthopaedic surgery providers in Texas.

See all adult reconstructive orthopaedic surgery providers in Texas →

Medicare billing

Part B allowed, 2024

$104,770

Medicare patients

137

Services billed

2,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ibuprofen	115	$521
Meloxicam	187	$505
Diclofenac Sodium ErDiclofenac Sodium	12	$445
Tramadol Hcl-AcetaminophenTramadol Hcl/Acetaminophen	48	$416
Acetaminophen-CodeineAcetaminophen With Codeine	34	$382
Diclofenac Sodium	13	$212
Tramadol Hcl	34	$177
Methylprednisolone	11	$114
Gabapentin	13	$90

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Edinburg

Zain SayeedEdinburg$15K
Tyler GoldbergAustin$4.6M
Antonia ChenDallas$3.8M
John BarringtonPlano$2.2M
Roger EmersonPlano$691K
Donald HohmanDallas$537K
Steven WeedenFort Worth$370K
Marcus FordFort Worth$296K
Richard ReitmanPlano$227K
Brian FullerCarrollton$218K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →